Open AccessComparison of Levetiracetam and sodium Valproate in migraine prophylaxis: A randomized placebo-controlled study
Author(s) -
Homa Sadeghian,
Rouzbeh Motiei-Langroudi
Publication year - 2014
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.144290
Subject(s) - levetiracetam , medicine , tolerability , migraine , placebo , gabapentin , anesthesia , randomized controlled trial , epilepsy , adverse effect , psychiatry , alternative medicine , pathology
Migraine is a chronic and disabling disorder. Treatment of migraine often comprises of symptomatic (abortive) and preventive (prophylactic) treatment. The current drugs used in migraine prophylaxis include antidepressant drugs (Serotonin Reuptake Inhibitors, Tricyclic antidepressants), and anti-epileptic drugs (valproate, gabapentin, etc).